Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
07/2004
07/08/2004US20040132800 aminomethyl- or ethyl-substituted indoles, tetrahydrocarbazoles and tetrahydropyrido[1,2-a]indoles
07/08/2004US20040132791 N-(on SO2 ) (2-hydroxy-3-substituted aminopropyl)-substituted; inhibiting retroviral replication
07/08/2004US20040132788 thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives; treating neurodegenerative disorders or pain.
07/08/2004US20040132786 Differential tumor cytotoxicity compounds and compositions
07/08/2004US20040132785 Thiolesters and uses thereof
07/08/2004US20040132781 Pyrazole compounds useful as protein kinase inhibitors
07/08/2004US20040132772 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis
07/08/2004US20040132762 Sulfonamide and sulfamide substituted imidazoquinolines
07/08/2004US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders
07/08/2004US20040132752 cyclic ureas and triazolones; treatment or prevention of excessive weight or obesity, and for treatment of Type II diabetes, arteriosclerosis, high blood pressure, depression, anxiety, anxiety neuroses, and schizophrenia.
07/08/2004US20040132741 N-sulfonylindoles and N-sulfonylindazoles; treating motor disorders, anxiety disorders or cognitive disorders, such as schizophrenia, depression, Alzheimer's disease or Parkinson's disease
07/08/2004US20040132736 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
07/08/2004US20040132732 Quinazolinones and derivatives thereof as factor Xa inhibitors
07/08/2004US20040132721 Treatment of airway disorders
07/08/2004US20040132719 Phenothiazine kinesin inhibitors
07/08/2004US20040132693 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE)
07/08/2004US20040132146 Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B
07/08/2004US20040132115 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity
07/08/2004US20040131885 Organic electroluminescent device and organic electroluminescent compound thereof
07/08/2004CA2511321A1 Pyrazole-derivatives as factor xa inhibitors
07/08/2004CA2511182A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors
07/08/2004CA2510851A1 Benzoxazines and derivatives thereof as inhibitors of pi3ks
07/08/2004CA2510848A1 Pyrimidine derivates for the treatment of abnormal cell growth
07/08/2004CA2510846A1 New carboxylic acid amides,the preparation thereof and their use as pharmaceutical compositions
07/08/2004CA2510620A1 Epothilone derivatives
07/08/2004CA2510471A1 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
07/08/2004CA2509405A1 Mek inhibiting oxa- and thia-diazol-2-yl phenylamine derivatives
07/08/2004CA2509403A1 Pyrazole compounds
07/08/2004CA2508657A1 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
07/08/2004CA2506826A1 Uracils having a herbicidal activity
07/07/2004EP1435356A1 Quinoline derivatives as CRTH2 antagonists
07/07/2004EP1435353A1 Novel heterocyclic compound and anti-inflammatory agent
07/07/2004EP1434778A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor
07/07/2004EP1434777A1 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system
07/07/2004EP1434776A1 Thiazolyl substituted aminopyrimidines as plant protection agents
07/07/2004EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
07/07/2004EP1434773A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
07/07/2004EP1434763A2 Beta-lactamyl vasopressin v1a antagonists
07/07/2004EP1434583A1 N-aroyl piperazine derivatives as orexin receptor antagonists
07/07/2004EP1047694B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
07/07/2004EP1006794A4 A method for treating or preventing alzheimer's disease
07/07/2004EP0946552B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
07/07/2004CN1511192A Production of polyketides
07/07/2004CN1511143A Herbicidal substituted benzoylpyrazoles
07/07/2004CN1156473C Hydrochloride of fused-heterocycle compound
07/07/2004CN1156472C Benzotrizole derivative as agro-chemical
07/07/2004CN1156471C 5-phridyl-1,3-azole compounds, process for producing the same and use thereof
07/07/2004CN1156470C New Substituted pyridyl keto enols
07/07/2004CN1156446C Indenoindolone compounds, their preparation and medicinal compositions containing them
07/06/2004US6759548 Dialkyl-halogenophenyl-substituted ketoenols
07/06/2004US6759415 Affinity with subtypes of somatostatin receptors
07/06/2004US6759414 Aromatic amides
07/06/2004US6759411 Heterocyclic piperidines as modulators of chemokine receptor activity
07/06/2004US6759409 Inhibitors of papilloma virus
07/06/2004US6759407 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, ESP as parasiticides
07/06/2004US6759406 Quaternary ammonium compounds
07/06/2004CA2303594C Compounds for treating and preventing diabetic complications
07/06/2004CA2119556C Substituted aryl- and heteroaryl-phenyloxazolidinones
07/01/2004WO2004055015A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/01/2004WO2004055011A1 Heterocyclic compounds as ccr5 antagonists
07/01/2004WO2004055004A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
07/01/2004WO2004055003A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
07/01/2004WO2004054972A1 N-(indolethyl-)cacloamine compounds
07/01/2004WO2004054624A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
07/01/2004WO2004054515A2 Thrombopoietin mimetics
07/01/2004WO2004046170A3 Tubulysins, method for producing the same and tubulysin preparations
07/01/2004WO2004043928A3 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
07/01/2004WO2004032929A3 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer’s disease
07/01/2004WO2004022540A3 Pyridazinone and pyridone derivatives as adenosine antagonists
07/01/2004WO2004017911A3 Protease inhibitors
07/01/2004WO2003093297A3 Protein kinase modulators and methods of use
07/01/2004US20040127708 antiviral activities; aids treatment
07/01/2004US20040127707 Novel phthalazinones
07/01/2004US20040127689 activated haptens useful for generating immunogens to HIV protease inhibitors
07/01/2004US20040127549 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
07/01/2004US20040127536 Indazole Derivatives
07/01/2004US20040127530 treating gram-negative microbial infections
07/01/2004US20040127528 Metalloproteinase inhibitors
07/01/2004US20040127527 Large conductance calcium-activated k channel opener
07/01/2004US20040127515 For therapy of hypertension, chronic obstructive pulmonary disease, organ damage, pain, diabetic nephropathy, dementia
07/01/2004US20040127513 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease
07/01/2004US20040127504 Administering benzimidazole compound for therapy of sexual dysfunction in a mammal
07/01/2004US20040127502 Use of pyrimidine compound galanin receptor subtype 3 (GAL3) antagonists, which may be classified as neutral antagonists, inverse agonists or allosteric modulators, to treat depressive disorders and/or anxiety
07/01/2004US20040127497 Pyridyl substituted heterocycles useful for treating or preventing HCV infection
07/01/2004US20040127477 Heterocyclic glycyl beta-alanine derivatives
07/01/2004US20040127432 new synthetic methods for the synthesis of epothilone A and epothilone B; macrolactonization;
07/01/2004US20040127426 Peptidic compounds as cysteine protease inhibitors
07/01/2004US20040124410 Novel organic semiconductor polymer and organic thin film transistor using the same
07/01/2004DE10260730A1 Neue substituierte stickstoffhaltige Heterobicyclen, deren Herstellung und deren Verwendung als Arzneimittel New substituted nitrogen containing heterobicycles, their preparation and their use as medicaments
07/01/2004DE10259407A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis
07/01/2004DE10259244A1 N-(Indolethyl-)cycloamin-Verbindungen N- (Indolethyl-) cyclo amine compounds
07/01/2004CA2549463A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
07/01/2004CA2510169A1 N-(indolethyl-)cycloamine compounds
07/01/2004CA2509244A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/01/2004CA2509239A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
07/01/2004CA2509233A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
06/2004
06/30/2004EP1434285A2 Organic semiconductor polymer and organic thin film transistor
06/30/2004EP1433788A1 Pyrazole-derivatives as factor Xa inhibitors
06/30/2004EP1433787A1 1,2,3-Thiadiazole derivatives, plant disease controller and method for using them
06/30/2004EP1433783A2 Naphthalenecarboxamides as tachykinin receptor antagonists